Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Clinical Trial to Measure the Impact of Retreatment With an Artemisinin-based Combination on Malaria Incidence and Its Potential Selection of Resistant Strains

NCT01374581 is registered in ClinicalTrials.gov with Universiteit Antwerpen as lead sponsor.

NCT NCT01374581
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01374581 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Clinical Trial to Measure the Impact of Retreatment With an Artemisinin-based Combination on Malaria Incidence and Its Potential Selection of Resistant Strains
Lead sponsor
Universiteit Antwerpen
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2012
Completion date
June 30, 2014
Enrollment
2,117 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

malaria